J. Ferlay, D. M. Parkin, and E. Steliarova-foucher, Estimates of cancer incidence and mortality in Europe in 2008, European Journal of Cancer, vol.46, issue.4, pp.765-81, 2010.
DOI : 10.1016/j.ejca.2009.12.014

B. Tretarre, L. Remontet, F. Menegoz, J. Mace-lesec-'h, P. Grosclaude et al., Les cancers de l???ovaire : incidence et mortalit?? en France, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.34, issue.2, pp.34-154, 2005.
DOI : 10.1016/S0368-2315(05)82707-3

A. Chevallier, Tumeurs de l'ovaire, 2000.

E. Guillot, Impact de la stadification chirurgicale initiale sur le pronostic des cancers épithéliaux de l'ovaire de stade I et II, 2008.

D. Querleu, Tumeurs de l'ovaire. Classification et histopathologie, Encycl Med Chir, pp.680-690, 1993.

M. Bazot, J. Nassar-slaba, I. Thomassin-nagara, A. Cortez, and E. Daraï, Pathologie organique de l'ovaire, EMC - Radiologie et imagerie m??dicale - G??nito-urinaire - Gyn??co-obst??tricale - Mammaire, vol.1, issue.2
DOI : 10.1016/S1879-8543(06)70640-1

I. Radiodiagnostic-urologie-gynécologie-coupier, M. Gauthier-villars, P. This, and D. Stoppa-lyonnet, Prédisposition génétique et cancer de l'ovaire, pp.34-600, 2004.

A. J. Sasco, J. Leroy-dudal, S. Kellouche, P. Gauduchon, C. et al., Epidémiologie des tumeurs de l'ovaire Gynécologie, 630-A-10 La micro-écologie des tumeurs épithéliales de l'ovaire, Encycl Med Chir Bull Cancer, vol.12, issue.9, pp.95-829, 2001.

M. Fournier, Atteinte ganglionnaire dans le cancer épithélial de l'ovaire

F. Cartographie, . Prédictifs, J. L. Benedet, H. Bender, H. Jones et al., (UFR des sciences médicales Bordeaux II, Bordeaux) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology, Int J Gynaecol Obstet, vol.146, issue.2, pp.70-209, 2000.

A. S. Bats and E. Barranger, Mise au point sur les cancers de l???ovaire, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.37, issue.37 2, pp.69-74, 2008.
DOI : 10.1016/S0368-2315(08)75575-3

E. Chereau, M. Ballester, R. Rouzier, C. Coutant, and E. Darai, Quels sont les meilleurs critères de résécabilité dans les cancers de l'ovaire de stade avancé? Bull Cancer, pp.96-1189, 2009.

D. Querleu and E. Leblanc, Cancer ??pith??lial de l'ovaire: bilan et chirurgie, EMC - Gyn??cologie, vol.1, issue.1, pp.630-640, 2000.
DOI : 10.1016/S0246-1064(00)00027-X

P. Morice, C. Uzan, S. P. Gouy, N. Lehmann, R. Kimmig et al., Chirurgie des tumeurs épithéliales malignes de l'ovaire Techniques chirurgicales - Gynécologie Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR), Encycl Med Chir Gynecol Oncol, vol.106, issue.1, pp.41-555, 2007.

L. Verleye, P. B. Ottevanger, W. Van-der-graaf, N. S. Reed, and I. Vergote, EORTC???GCG process quality indicators for ovarian cancer surgery, European Journal of Cancer, vol.45, issue.4, pp.517-543, 2009.
DOI : 10.1016/j.ejca.2008.09.031

G. D. Aletti, S. C. Dowdy, K. C. Podratz, C. , and W. A. , Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer, American Journal of Obstetrics and Gynecology, vol.197, issue.6, pp.197-676, 2007.
DOI : 10.1016/j.ajog.2007.10.495

D. Querleu, L. Gladieff, G. Ferron, and P. And-rouge, Vers une évolution du dogme de la chirurgie "optimale" dans les cancers de l'ovaire, Bull Cancer, issue.12, pp.96-1175, 2009.

E. Vincens, B. Lauratet, J. P. Lefranc, D. Querleu, E. Leblanc et al., Classification et morbidités des chirurgies de résection dans les cancers de l'ovaire Intervention de Hudson (ovariectomie élargie) pour cancer de l'ovaire, Chirurgie des cancers gynécologiques, pp.73-80, 2009.

D. Elias and S. Gaujoux, Traitement des pathologies tumorales du péritoine Gastro-entérologie, 9-120-A-60, Encycl Med Chir, pp.15-30, 2010.

F. Ghezzi, A. Cromi, S. Uccella, V. Bergamini, S. Tomera et al., Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer, Gynecologic Oncology, vol.105, issue.2, pp.409-422, 2007.
DOI : 10.1016/j.ygyno.2006.12.025

P. Desfeux, G. Chatellier, A. S. Bats, F. Larousserie, C. Bensaid et al., Effet de la voie d'abord sur la stadification chirurgicale des lésions ovariennes frontières et des cancers à un stade précoce, Bull Cancer, issue.7, pp.93-723, 2006.

R. Naik, A. Nordin, P. A. Cross, D. Hemming, A. De-barros-lopes et al., Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?, Gynecol Oncol, issue.2, pp.78-176, 2000.

F. Narducci, A. S. Bats, B. Loic, C. Bensaid, and F. Lecuru, Cancer de l'ovaire de stade avancé : chirurgie initiale ou intervallaire ? Bull Cancer, pp.96-1183, 2009.

I. Vergote, C. G. Trope, F. Amant, G. B. Kristensen, T. Ehlen et al., Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer, New England Journal of Medicine, vol.363, issue.10, pp.943-53, 2010.
DOI : 10.1056/NEJMoa0908806

C. D. Atkins, Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer 363(24): p. 2371-2; author reply 72. 37. Standards, Options: Recommandations pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l'ovaire. Traitement chirurgical (rapport intégral). FNCLCC, N Engl J Med, 2007.

T. Lowe, B. Ferrell, and L. Leong, Quality-of-Life Issues in the Management of Epithelial Ovarian Cancer, Current Treatment Options in Oncology, vol.101, issue.6, pp.402-418, 2007.
DOI : 10.1093/jnci/djg036

C. Lhomme and P. Pautier, Facteurs pronostiques et chimioth??rapie de premi??re ligne des ad??nocarcinomes ovariens, EMC - Gyn??cologie, vol.1, issue.1
DOI : 10.1016/S0246-1064(00)00033-5

G. Lhomme, C. Even, C. Morice, P. Balleyguier, C. Petrella et al., Chimiothérapie de première ligne des adénocarcinomes ovariens de stade avancé, Bull Cancer, issue.12, pp.630-640, 2000.

R. A. Burger, Overview of anti-angiogenic agents in development for ovarian cancer, Gynecologic Oncology, vol.121, issue.1, pp.230-238, 2011.
DOI : 10.1016/j.ygyno.2010.11.035

L. Gladieff, E. Chatelut, F. Dalenc, G. G. Ferron, A. Martinez et al., Bases pharmacologiques de la chimiothérapie intrapéritonéale 45. Standards, Options: Recommandations pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l'ovaire. Traitement médical de première ligne (rapport abrégé, mise à jour, Bull Cancer FNCLCC, issue.1212, pp.96-1235, 2008.

E. Cotte, O. Glehen, F. Mohamed, F. Lamy, C. Falandry et al., Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients, World J Surg, issue.9, pp.31-1813, 2007.

A. Maggioni, P. Benedetti-panici, T. Dell-'anna, F. Landoni, A. Lissoni et al., Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis, British Journal of Cancer, vol.49, issue.suppl, pp.95-699, 2006.
DOI : 10.1006/gyno.1993.1085

P. B. Panici, A. Maggioni, N. Hacker, F. Landoni, S. Ackermann et al., Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial, JNCI: Journal of the National Cancer Institute, vol.97, issue.8, pp.97-560, 2005.
DOI : 10.1200/JCO.2001.19.7.1901

F. Joulie, P. Morice, A. Rey, A. Thoury, S. Camatte et al., Les métastases ganglionnaires du cancer épithélial de l'ovaire sont elles chimiosensibles? Etude comparative de la lymphadénectomie première ou après chimiothérapie, Gynecol Obstet Fertil, issue.6, pp.32-502, 2004.

D. Querleu, G. Ferron, E. Leblanc, E. Leblanc, P. Morice et al., Lymphadénectomie lombo-aortique dans les cancers gynécologiques Gynécologie Curage ganglionnaire lomboaortique, Encycl Med Chir Chirurgie des cancers gynécologiques, pp.41-734, 2004.

O. Graesslin, P. Terrosi, C. Avisse, J. Journu, C. Quéreux et al., Curages pelviens par laparotomie, EMC - Techniques chirurgicales - Gyn??cologie, vol.2, issue.1
DOI : 10.1016/S1624-5857(07)73026-0

T. Chirurgicales-gynécologie-leblanc, E. Querleu, D. Narducci, F. , C. et al., Technique des lymphadénectomies pelviennes laparoscopiques Techniques chirurgicales -Gynécologie Voie d'abord coelioscopique du curage lombo-aortique, Encycl Med Chir Gynecol Obstet Fertil, vol.38, issue.2, pp.41-732, 2005.

D. Rustin, G. J. Van-der-burg, M. E. Griffin, C. L. Guthrie, D. Lamont et al., Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial, The Lancet, vol.376, issue.9747, pp.98-575, 2009.
DOI : 10.1016/S0140-6736(10)61268-8

J. P. Guastalla, R. L. Torrès, S. Jung, C. Eulenburg, V. Mueller et al., Surveillance et stratégie de traitement des rechutes de tumeurs de l'ovaire Gynécologie, 630-K-10 Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer, Encycl Med Chir Eur J Surg Oncol, issue.6, pp.36-583, 2001.

J. M. Classe, L. Catala, F. Marchal, G. Ferron, F. Dravet et al., Récidives locorégionales du cancer de l'ovaire: place de la chirurgie, Bull Cancer, issue.11, pp.91-827, 2004.

N. Mantel, Evaluation of survival date and two new rank order statistics arising in its consideration, Cancer Chemother Rep, vol.50, pp.163-70, 1966.

E. L. Kaplan and P. Meier, Nonparametric estimation from incomplete observations J Am Statist Soc, pp.457-81, 1958.
DOI : 10.1007/978-1-4612-4380-9_25

D. R. Cox and D. Oakes, Analysis of survival data, 1990.

B. A. Goff, B. J. Matthews, M. Wynn, H. G. Muntz, D. M. Lishner et al., Ovarian cancer: Patterns of surgical care across the United States, Gynecologic Oncology, vol.103, issue.2, pp.383-90, 2006.
DOI : 10.1016/j.ygyno.2006.08.010

S. Tingulstad, F. E. Skjeldestad, H. , and B. , The effect of centralization of primary surgery on survival in ovarian cancer patients, Obstet Gynecol, vol.102, issue.3, pp.499-505, 2003.

K. C. Giede, K. Kieser, J. Dodge, and B. Rosen, Who should operate on patients with ovarian cancer? An evidence-based review, Gynecologic Oncology, vol.99, issue.2, pp.447-61, 2005.
DOI : 10.1016/j.ygyno.2005.07.008

S. M. Eisenkop and N. M. Spirtos, What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?, Gynecologic Oncology, vol.82, issue.3, pp.489-97, 2001.
DOI : 10.1006/gyno.2001.6312

J. K. Chan, D. S. Kapp, J. Y. Shin, A. Husain, N. N. Teng et al., Influence of the Gynecologic Oncologist on the Survival of Ovarian Cancer Patients, Obstetrics & Gynecology, vol.109, issue.6, pp.109-1342, 2007.
DOI : 10.1097/01.AOG.0000265207.27755.28

D. Querleu and F. Narducci, Quality control criteria in the surgical management of advanced ovarian cancers, Bull Cancer, vol.12, pp.1255-62, 2009.

R. Giannice, T. Susini, G. Ferrandina, A. Poerio, P. A. Margariti et al., Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III patients, Gynecol Oncol Cancer, vol.107, issue.728, pp.92-154, 1998.

W. A. Cliby, G. D. Aletti, T. O. Wilson, and K. C. Podratz, Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?, Gynecologic Oncology, vol.103, issue.3, pp.797-801, 2006.
DOI : 10.1016/j.ygyno.2006.08.047

J. J. Herzog, Assessing the adequacy of surgical staging for ovarian cancer, Gynecologic Oncology, vol.103, issue.3, pp.781-783, 2006.
DOI : 10.1016/j.ygyno.2006.10.017

G. D. Aletti, S. C. Dowdy, B. S. Gostout, M. B. Jones, C. R. Stanhope et al., Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer, Obstetrics & Gynecology, vol.107, issue.1, pp.77-85, 2006.
DOI : 10.1097/01.AOG.0000192407.04428.bb

D. S. Chi, E. L. Eisenhauer, O. Zivanovic, Y. Sonoda, and N. R. Abu-rustrum, Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm, Gynecologic Oncology, vol.114, issue.1, pp.26-31, 2009.
DOI : 10.1016/j.ygyno.2009.03.018

R. E. Bristow, R. S. Tomacruz, D. K. Armstrong, E. L. Trimble, and F. J. Montz, Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis, J Clin Oncol, issue.5, pp.20-1248, 2002.

D. Re, F. Baiocchi, and G. , Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium, Int J Gynecol Cancer, vol.10, issue.6, pp.435-477, 2000.

F. Parazzini, G. Valsecchi, G. Bolis, P. Guarnerio, S. Reina et al., Pelvic and Paraortic Lymph Nodal Status in Advanced Ovarian Cancer and Survival, Gynecologic Oncology, vol.74, issue.1, pp.7-11, 1999.
DOI : 10.1006/gyno.1999.5397

A. Bernier-duprelle, C. Uzan, S. Gouy, A. Kane, P. Morice et al., Lymph node surgery and ovarian cancer. e-mémoire Académ Nation Chir Lymph node metastasis in ovarian cancer: difference between serous and nonserous primary tumors of retroperitoneal lymph nodes in the treatment of ovarian cancer, Gynecol Oncol Int J Clin Oncol, vol.81, issue.823, pp.36-45, 2005.

C. Pomel and J. Dauplat, Prise en charge chirurgicale des tumeurs ??pith??liales malignes de l???ovaire, Journal de Chirurgie, vol.141, issue.5, pp.277-84, 2004.
DOI : 10.1016/S0021-7697(04)95334-3

N. Roger, Y. Zafrani, C. Uzan, S. Gouy, A. Rey et al., Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?, Annals of Surgical Oncology, vol.97, issue.1, pp.333-341, 2008.
DOI : 10.1016/0002-9378(86)90817-3

S. Tangjitgamol, S. Manusirivithaya, C. Sheanakul, S. Leelahakorn, M. Sripramote et al., Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma?, International Journal of Gynecological Cancer, vol.13, issue.3, pp.13-297, 2003.
DOI : 10.1046/j.1525-1438.2003.13192.x

P. Harter, K. Gnauert, R. Hils, T. G. Lehmann, A. Fisseler-eckhoff et al., Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer, International Journal of Gynecological Cancer, vol.17, issue.6, pp.17-1238, 2007.
DOI : 10.1111/j.1525-1438.2007.00931.x

A. Ayhan, M. Gultekin, P. Dursun, N. U. Dogan, G. Aksan et al., Metastatic lymph node number in epithelial ovarian carcinoma: Does it have any clinical significance?, Gynecologic Oncology, vol.108, issue.2, pp.428-460, 2001.
DOI : 10.1016/j.ygyno.2007.09.014

G. D. Aletti, S. C. Dowdy, K. C. Podratz, C. , and W. A. , Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer, American Journal of Obstetrics and Gynecology, vol.195, issue.6, pp.1862-1870, 0195.
DOI : 10.1016/j.ajog.2006.06.068

J. K. Chan, R. Urban, J. M. Hu, J. Y. Shin, A. Husain et al., The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13???918 patients, British Journal of Cancer, vol.95, issue.12, pp.96-1817, 2007.
DOI : 10.1046/j.1525-1438.2003.13192.x

R. Rouzier, C. Bergzoll, J. L. Brun, G. Dubernard, F. Selle et al., The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) database, BJOG: An International Journal of Obstetrics & Gynaecology, vol.202, issue.12, pp.117-1451, 2010.
DOI : 10.1016/0002-9378(86)90817-3

A. Ayhan, M. Gultekin, C. Taskiran, N. Y. Celik, A. Usubutun et al., Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables, Gynecologic Oncology, vol.97, issue.2, pp.97-400, 2005.
DOI : 10.1016/j.ygyno.2005.01.038

P. Hillemanns, J. Reiff, H. Stepp, and P. Soergel, Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report, Lasers in Medical Science, vol.7, issue.3, pp.131-136, 2007.
DOI : 10.1007/s10103-006-0428-4

A. Ayhan, M. Gultekin, C. Taskiran, P. Dursun, P. Firat et al., Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects, International Journal of Gynecological Cancer, vol.17, issue.1, pp.68-75, 2007.
DOI : 10.1111/j.1525-1438.2006.00777.x

I. T. Takac and J. D. Jeon, Role of appendectomy in predicting lymph node metastases in patients with ovarian cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.88, issue.2, pp.159-63, 2000.
DOI : 10.1016/S0301-2115(99)00151-7

N. Concin, L. Hefler, J. Van-bavel, E. Mueller-holzner, A. Zeimet et al., Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases, Gynecologic Oncology, vol.89, issue.1, pp.9-15, 2003.
DOI : 10.1016/S0090-8258(02)00147-6

H. Negishi, M. Takeda, T. Fujimoto, Y. Todo, Y. Ebina et al., Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer, Gynecologic Oncology, vol.94, issue.1, pp.94-161, 2004.
DOI : 10.1016/j.ygyno.2004.04.023

P. Morice, F. Joulie, S. Camatte, D. Atallah, R. Rouzier et al., Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications, Journal of the American College of Surgeons, vol.197, issue.2, pp.198-205, 2003.
DOI : 10.1016/S1072-7515(03)00234-5

A. Pereira, J. F. Magrina, V. Rey, M. Cortes, and P. M. Magtibay, Pelvic and aortic lymph node metastasis in epithelial ovarian cancer, Gynecologic Oncology, vol.105, issue.3, pp.604-612, 2007.
DOI : 10.1016/j.ygyno.2007.01.028

T. J. Selman, C. H. Mann, J. Zamora, and K. S. Khan, A systematic review of tests for lymph node status in primary endometrial cancer, BMC Women's Health, vol.181, issue.1, p.8, 2008.
DOI : 10.1148/radiology.181.1.1887062

T. Kamura, Lymph nodes in gynecologic oncology: Enduring importance and challenge, International Journal of Gynecology & Obstetrics, vol.99, issue.(1), pp.1-2, 2009.
DOI : 10.1016/j.ijgo.2007.06.001

A. Martinez, C. Pomel, E. Mery, D. Querleu, L. Gladieff et al., Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, Gynecologic Oncology, vol.121, issue.2, 2011.
DOI : 10.1016/j.ygyno.2010.12.328

D. Querleu, E. Leblanc, P. Morice, and G. Ferron, Curage ganglionnaire pelvien, Chirurgie des cancers gynécologiques, pp.148-58, 2009.

D. Querleu, E. Leblanc, P. Morice, and G. Ferron, Généralités sur la chirurgie ganglionnaire, Chirurgie des cancers gynécologiques, pp.141-146, 2009.

P. B. Panici and R. Angioli, Role of lymphadenectomy in ovarian cancer, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.16, issue.4, pp.529-51, 2002.
DOI : 10.1053/beog.2002.0301

C. Zinzindohoue, R. Lujan, S. Boulet, C. Spirito, and J. Y. Bobin, La lymphad??nectomie lombo-aortique et pelvienne dans les cancers ??pith??liaux de l'ovaire. A propos d'une s??rie de 86 cas, Annales de Chirurgie, vol.125, issue.2, pp.125-163, 2000.
DOI : 10.1016/S0003-3944(00)00233-9

S. D. Beck, R. S. Foster, R. Bihrle, J. P. Donohue, and L. H. Einhorn, Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer, pp.110-1235, 2007.

F. Iborra, C. Avances, S. Culine, A. Houlgatte, and N. Mottete, Que reste-t-il du??curage lomboaortique dans??le??traitement du??cancer du??testicule?, Annales d'Urologie, vol.41, issue.3, pp.41-116, 2007.
DOI : 10.1016/j.anuro.2007.04.002

L. De-poncheville, F. Perrotin, T. Lefrancq, J. Lansac, and G. Body, Does paraaortic lymphadenectomy have a benefit in the treatment of ovarian cancer??that is apparently confined to the ovaries?, European Journal of Cancer, vol.37, issue.2, pp.210-215, 2001.
DOI : 10.1016/S0959-8049(00)00377-4

J. Dubuc-lissoir, L'avenir de la dissection ganglionnaire rétropéritonéale, J Gynecol Obstet Biol Reprod, vol.29, issue.3, pp.276-284, 2000.

J. Warwick, E. Vardaki, N. Fattizzi, and I. Mcneish, Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies, Gynecol Oncol, issue.116, pp.1225-1266, 2009.

M. Suzuki, M. Ohwada, and I. Sato, Pelvic lymphocysts following retroperitoneal lymphadenectomy: Retroperitoneal partial ???no-closure??? for ovarian and endometrial cancers, Journal of Surgical Oncology, vol.161, issue.3, pp.149-52, 1998.
DOI : 10.1016/0002-9378(89)90757-6

P. Morice, N. Lassau, P. Pautier, C. Haie-meder, C. Lhomme et al., Retroperitoneal Drainage After Complete Para-aortic Lymphadenectomy for Gynecologic Cancer, Obstetrics & Gynecology, vol.97, issue.2, pp.97-243, 2001.
DOI : 10.1097/00006250-200102000-00015

V. Beesley, M. Janda, E. Eakin, A. Obermair, and D. Battistutta, Lymphedema after gynecological cancer treatment, Cancer, vol.33, issue.12, pp.2607-2621, 2007.
DOI : 10.1016/S0894-1130(01)80043-0

URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.22684/pdf

M. Ryan, M. C. Stainton, E. K. Slaytor, C. Jaconelli, S. Watts et al., Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer, The Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.18, issue.2, pp.43-148, 2003.
DOI : 10.1006/gyno.1999.5660

N. Boran, A. P. Cil, G. Tulunay, N. Ozgul, and M. F. Kose, Chylous ascites following para-aortic lymphadenectomy: a case report, Gynecologic Oncology, vol.93, issue.3, pp.93-711, 2004.
DOI : 10.1016/j.ygyno.2004.03.022

J. K. Chan, E. G. Munro, M. K. Cheung, A. Husain, N. N. Teng et al., Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients, Obstetrics & Gynecology, vol.109, issue.1, pp.12-21, 2007.
DOI : 10.1097/01.AOG.0000249610.95885.ef

W. M. Rich, Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients, Obstetrics & Gynecology, vol.109, issue.4, pp.1000-1001, 2007.
DOI : 10.1097/01.AOG.0000260085.24403.b3

J. B. Trimbos, I. Vergote, G. Bolis, J. B. Vermorken, C. Mangioni et al., Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial, JNCI Journal of the National Cancer Institute, vol.37, issue.3, pp.95-113, 2003.
DOI : 10.1016/0090-8258(90)90370-Z

A. Abe, H. Furumoto, M. Irahara, H. Ino, M. Kamada et al., The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer, Journal of Obstetrics and Gynaecology Research, vol.97, issue.5, pp.36-1023, 2010.
DOI : 10.1097/01.AOG.0000249610.95885.ef

D. Salet-lizée and S. Alsary, The place of lumbo-aortic lymph node dissection in the treatment of ovarian cancer, J Chir, issue.145 4, pp.12-45, 2008.

N. F. Hacker, S. Valmadre, and G. Robertson, Management of retroperitoneal lymph nodes in advanced ovarian cancer, International Journal of Gynecological Cancer, vol.18, issue.1, pp.7-10, 2008.
DOI : 10.1111/j.1525-1438.2007.01097.x

D. G. Allen and J. Coulter, Survival of patients with epithelial ovarian cancer and the effect of lymphadenectomy in those with stage 3 disease, Aust N Z J Obstet Gynaecol, vol.39, issue.4, pp.420-424, 1999.

U. Saygili, S. Guclu, T. Uslu, O. Erten, S. Ture et al., Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study, Journal of Surgical Oncology, vol.78, issue.3, pp.81-132, 2002.
DOI : 10.1002/jso.1158

S. C. Crawford, P. A. Vasey, J. Paul, A. Hay, J. A. Davis et al., Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial, J Clin Oncol, issue.34, pp.23-8802, 2005.

S. Isonishi, S. Niimi, H. Sasaki, K. Ochiai, M. Yasuda et al., Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer, Gynecologic Oncology, vol.93, issue.3, pp.93-647, 2004.
DOI : 10.1016/j.ygyno.2004.03.006

A. Hayasi, Y. Nishida, S. Yoshii, S. Y. Kim, H. Uda et al., Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy, Cancer Sci, issue.10, pp.100-1191, 2009.

C. Uzan, P. Morice, A. Rey, P. Pautier, S. Camatte et al., Outcomes After Combined Therapy Including Surgical Resection in Patients with Epithelial Ovarian Cancer Recurrence(s) Exclusively in Lymph Nodes, Annals of Surgical Oncology, vol.13, issue.7, pp.11-658, 2004.
DOI : 10.1245/ASO.2004.11.023

P. B. Panici, G. Perniola, R. Angioli, M. A. Zullo, N. Manci et al., Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery, Int J Gynecol Cancer, issue.6, pp.17-1245, 2007.

D. Grahek and N. Hassan-sebbag, Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers Bull Cancer, pp.96-1163, 2009.

S. K. Chambers, Systematic Lymphadenectomy in Advanced Epithelial Ovarian Cancer: Two Decades of Uncertainty Resolved, JNCI: Journal of the National Cancer Institute, vol.97, issue.8, pp.548-557, 2005.
DOI : 10.1200/JCO.2002.20.19.3944

P. Blanchard, A. Plantade, C. Pages, P. Afchain, C. Louvet et al., Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors, Gynecologic Oncology, vol.104, issue.1, pp.41-46, 2007.
DOI : 10.1016/j.ygyno.2006.06.039

R. Rosenberg, J. Friederichs, T. Schuster, R. Gertler, M. Maak et al., Prognosis of Patients With Colorectal Cancer Is Associated With Lymph Node Ratio, Annals of Surgery, vol.248, issue.6, pp.248-968, 2008.
DOI : 10.1097/SLA.0b013e318190eddc

P. Morice, Y. Zafrani, C. Uzan, F. Narducci, and E. Leblanc, Faut-il arr??ter les curages lombo-aortiques syst??matiques dans les cancers de l???ovaire???, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.11, pp.35-1167, 2007.
DOI : 10.1016/j.gyobfe.2007.09.007

J. Chan, K. Fuh, J. Shin, M. Cheung, C. Powell et al., The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?, British Journal of Cancer, vol.322, issue.7, pp.98-1191, 2008.
DOI : 10.1056/NEJM199004123221501

B. Resch, Pour ou contre le curage lombo-aortique dans les cancers de l???ovaire???, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.11, pp.35-1166, 2007.
DOI : 10.1016/j.gyobfe.2007.09.005

R. Villet, Contre le curage lomboaortique syst??matique dans la prise en charge des cancers de l???ovaire, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.11, pp.1170-1171, 2007.
DOI : 10.1016/j.gyobfe.2007.09.006

D. Bois, A. Reuss, A. Harter, P. Pujade-lauraine, E. Ray-coquard et al., Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials, J Clin Oncol, issue.10, pp.28-1733, 2010.

H. S. Kim, W. Ju, B. C. Jee, Y. B. Kim, N. H. Park et al., Systematic Lymphadenectomy for Survival in Epithelial Ovarian Cancer, International Journal of Gynecological Cancer, vol.19, issue.4, pp.520-528, 2010.
DOI : 10.1111/IGC.0b013e3181d6de1d

J. M. Classe, E. Cerato, C. Boursier, J. Dauplat, C. Pomel et al., Impact des curages r??trop??riton??aux sur la survie des patientes atteintes d???un cancer de l???ovaire ?? un stade avanc????: le protocole CARACO, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.40, issue.3, 2011.
DOI : 10.1016/j.jgyn.2011.02.009

I. Jaffre, V. Bordes, M. Dejode, F. Dravet, C. et al., Cancer de l'ovaire à un stade avancé: la place des curages ganglionnaires, Bull Cancer, vol.97, issue.1, pp.65-71, 2010.